59 Recruiting Studies Using Dupilumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Dupilumab
Pharmacokinetics and Tolerability of Subcutaneous Dupilumab Coformulated With Berahyaluronidase Alfa and Dupilumab Without Berahyaluronidase Alfa in Healthy Participants
📍 Clinical Pharmacology of Miami- Site Number : 8400001 — Hialeah, Florida
Healthy Volunteers
View Study & Checklist ➔Investigating Dupilumab's Effect in Asthma by Genotype
📍 Boston Children's Hospital — Boston, Massachusetts
Asthma
View Study & Checklist ➔A U.S. Registry of Eosinophilic Esophagitis Pediatric, Adolescent and Adult Patients Treated With DUPIXENT® As Standard of Care
📍 Phoenix Childrens Hospital — Phoenix, Arizona
Eosinophilic Esophagitis (EoE)
View Study & Checklist ➔Study of Patients Receiving DUPIXENT® for Atopic Dermatitis (AD)
📍 Regeneron Investigational Site — Birmingham, Alabama
Dermatitis, Atopic
View Study & Checklist ➔Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
📍 Kern Research, Inc — Bakersfield, California
Asthma
View Study & Checklist ➔A Study of Long-term Effect of Dupilumab on Skin Barrier Function in Pediatric Participants With Atopic Dermatitis
📍 National Jewish Health Medical Center- Site Number : 8400001 — Denver, Colorado
Dermatitis Atopic
View Study & Checklist ➔Short-Term Linvoseltamab Treatment on Top of Chronic Dupilumab Treatment for Adults With Severe Immunoglobulin E (IgE)-Mediated Food Allergy
📍 University of South Florida — Tampa, Florida
Food Allergy
View Study & Checklist ➔The Effects of Dupilumab on Allergic Contact Dermatitis
📍 Brigham and Women's Hospital, Department of Dermatology — Boston, Massachusetts
Allergic Contact Dermatitis
View Study & Checklist ➔Dupixent Study for Alternate Administration
📍 Madigan Army Medical Center — Tacoma, Washington
Nasal Polyps
View Study & Checklist ➔Prevention of Asthma Exacerbations Using Dupilumab in Urban Children and Adolescents
📍 Children's Hospital Colorado: Allergy Program — Aurora, Colorado
Asthma
View Study & Checklist ➔Dupilumab for Eosinophilic Esophagitis With Severe Strictures
📍 University of North Carolina at Chapel Hill — Chapel Hill, North Carolina
Eosinophilic Esophagitis
View Study & Checklist ➔An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in Moderate-to-Severe Atopic Dermatitis
📍 Investigational Site — Darlinghurst, New South Wales
Atopic Dermatitis
View Study & Checklist ➔A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 1)
📍 Dermatology Research Associates - Los Angeles- Site Number : 8400004 — Los Angeles, California
Lichen Simplex Chronicus
View Study & Checklist ➔Observational Study of Patients Receiving Dupixent® for Atopic Dermatitis (AD)
📍 Investigational Site Number : 0320013 — Pilar, Buenos Aires
Dermatitis Atopic
View Study & Checklist ➔A Study Assessing Esophageal Function and Remodeling With Dupilumab Compared With Placebo for 24 Weeks Followed by 104 Weeks Open Label in Adult Participants With EoE (REMOdeling With Dupilumab in Eosinophilic Esophagitis Long-term Trial)
📍 United Gastroenterologists - Murrieta- Site Number : 8400001 — Murrieta, California
Eosinophilic Oesophagitis
View Study & Checklist ➔Mechanisms of Benefit of IL4RA Inhibition in Aspirin-Exacerbated Respiratory Disease
📍 Brigham and Women's Hospital — Boston, Massachusetts
Nasal Polyps
View Study & Checklist ➔A Study to Investigate Improvement in Pruritus of Lichen Simplex Chronicus With Dupilumab Injections Compared With Placebo in Male and Female Participants Aged at Least 18 Years (STYLE 2)
📍 Cosmetic Dermatology of Orange County- Site Number : 8400232 — Anaheim, California
Lichen Simplex Chronicus
View Study & Checklist ➔A Study to Investigate the Efficacy and Safety of Dupilumab Therapy Compared With Placebo in Participants Aged ≥18 Years With Moderately to Severely Active Ulcerative Colitis With an Eosinophilic Phenotype (LIBERTY-UC SUCCEED (Study in UC for Clinical Efficacy Evaluation of Dupilumab))
📍 Om Research- Site Number : 8400029 — Apple Valley, California
Colitis Ulcerative
View Study & Checklist ➔Dupilumab Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
📍 University of South Florida Asthma, Allergy and Immunology — Tampa, Florida
Severe Eosinophilic Chronic Sinusitis Without Nasal Polyposis
View Study & Checklist ➔Study Assessing the Long-term Effect of Dupilumab on Prevention of Lung Function Decline in Adult Patients With Uncontrolled Moderate to Severe Asthma
📍 Cullman Research Center- Site Number : 8400001 — Cullman, Alabama
Asthma
View Study & Checklist ➔Using a Contact Dermatitis Model With Biologic Medications to Study Skin Inflammation
📍 University of Massachusetts Chan Medical School — Worcester, Massachusetts
Skin Inflammation
View Study & Checklist ➔Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)
📍 Regeneron Investigational Site — Birmingham, Alabama
Atopic Dermatitis
View Study & Checklist ➔Dupilumab Effects Against Aeroallergen Challenge
📍 Biogenics Research Chamber — San Antonio, Texas
Asthma, Allergic
View Study & Checklist ➔Real-World Effectiveness of Dupilumab in Patients With Prurigo Nodularis: An Observational Study
📍 Medical Dermatology Specialists Site Number : 8400005 — Phoenix, Arizona
Prurigo Nodularis
View Study & Checklist ➔A Study to Learn How Well Dupilumab Works in Adult and Adolescent Participants With Eosinophilic Gastritis With or Without Eosinophilic Duodenitis and the Side Effects it May Have
📍 Phoenix Childrens Hospital — Phoenix, Arizona
Eosinophilic Gastritis (EoG)
View Study & Checklist ➔Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa Rica
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
Atopic Dermatitis
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe Eczema
📍 Vital Prospects Clinical Research Institute., PC — Tulsa, Oklahoma
Atopic Dermatitis
View Study & Checklist ➔Olfactory Outcomes of Dupilumab Treatment for Nasal Polyposis
📍 St. Joseph's Health Care — London, Ontario
Chronic Rhinosinusitis With Nasal Polyps
View Study & Checklist ➔A Study Assessing the Effect of Dupilumab on Inducing Clinical Remission in Asthma
📍 Sir Charles Gairdner Hospital — Nedlands, Western Australia
Asthma Control
View Study & Checklist ➔Interleukin-4Ra Blockade by Dupilumab Decreases Staphylococcus Colonization and Increases Microbial Diversity in CRSwNP
📍 University of Virginia Health System — Charlottesville, Virginia
Nasal Polyps
View Study & Checklist ➔Dupixent in Adults With Refractory Post-Burn Pruritus in an Ambulatory Clinic
📍 Akron Children's Hospital — Akron, Ohio
Pruritis
View Study & Checklist ➔A Study of Dupilumab in Small Children With an Allergic Condition of the Esophagus (Food Pipe): Eosinophilic Esophagitis
📍 Phoenix Childrens Hospital — Phoenix, Arizona
Eosinophilic Esophagitis (EoE)
View Study & Checklist ➔Dupilumab Treatment Effects in an Ethnically Diverse Population With Chronic Rhinosinusitis With Nasal Polyposis
📍 Montefiore Medical Center — The Bronx, New York
Chronic Rhinosinusitis With Nasal Polyps
View Study & Checklist ➔Molecular Signatures of Cutaneous Dupilumab Response
📍 University of California, San Francisco — San Francisco, California
Atopic Dermatitis
View Study & Checklist ➔Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer
📍 CHUM — Montreal, Quebec
Non-Small Cell Lung Cancer
View Study & Checklist ➔Dupilumab in the Treatment of Pediatric Alopecia Areata
📍 University of California, Irvine — Irvine, California
Alopecia Areata
View Study & Checklist ➔Viral Infection in Asthma (VIA) Study
📍 University of Virginia — Charlottesville, Virginia
Asthma
View Study & Checklist ➔Dupilumab as Add-On Therapy for Hypereosinophilic Syndrome With Partial Clinical Response to Eosinophil-Depleting Biologic Agents
📍 National Institutes of Health Clinical Center — Bethesda, Maryland
Hypereosinophilic Syndrome
View Study & Checklist ➔Neoadjuvant Dupilumab, Pembrolizumab, Paclitaxel, and Carboplatin in Locally Advanced Triple Negative Breast Cancer
📍 Mount Sinai Health System — New York, New York
Locally Advanced Triple Negative Breast Cancer
View Study & Checklist ➔Ethnic Differences in Mechanisms of Action of Dupilumab
📍 University of Michigan — Ann Arbor, Michigan
Atopic Dermatitis
View Study & Checklist ➔Leveraging Pharmacogenomics in Asthma for Predication, Mechanism and Endotyping
📍 Mayo Clinic — Scottsdale, Arizona
Moderate to Severe Asthma
View Study & Checklist ➔Repurposing Dupilumab for Management of Pruritic Genetic Inflammatory Skin Disorders
📍 Ann & Robert H. Lurie Children's Hospital of Chicago — Chicago, Illinois
Skin Diseases
View Study & Checklist ➔Effect of Dupilumab on the Muscle Function of the Esophagus (food Pipe) in Participants with Eosinophilic Esophagitis (EoE)
📍 University of California San Diego (UCSD) Health Medical center — La Jolla, California
Eosinophilic Esophagitis (EoE)
View Study & Checklist ➔Dupilumab De-escalation in Pediatric Atopic Dermatitis
📍 Johns Hopkins Univerisity — Baltimore, Maryland
Atopic Dermatitis
View Study & Checklist ➔Olfactory Cleft Obstruction and Electrophysiological Field Potentials Predict Olfactory Restoration by Dupilumab in CRSwNP Patients.
📍 Northwestern University Feinberg School of Medicine — Chicago, Illinois
Chronic Rhinosinusitis Phenotype With Nasal Polyps (CRSwNP)
View Study & Checklist ➔Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)
📍 Kern Allergy and Medical Research- Site Number : 8400016 — Bakersfield, California
Pruritus
View Study & Checklist ➔A Study to Evaluate Efficacy of Remibrutinib Compared to Dupilumab at Early Timepoints in Adults With Chronic Spontaneous Urticaria Inadequately Controlled by Second Generation H1-antihistamines
📍 Allervie Clinical Research — Birmingham, Alabama
Chronic Spontaneous Urticaria (CSU)
View Study & Checklist ➔A Study to Investigate the Pharmacokinetics and Safety of Dupilumab in Participants ≥6 Months to <18 Years of Age With Prurigo Nodularis
📍 Stanford University Medical Center CTRU - 800 Welch Road- Site Number : 8400021 — Palo Alto, California
Prurigo Nodularis
View Study & Checklist ➔Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Non-Small Cell Lung Cancer
View Study & Checklist ➔Regeneron AA Multicenter (Dupilumab)
📍 University of California, Irvine — Irvine, California
Alopecia Areata
View Study & Checklist ➔An Observational Retrospective Cohort Study Being Conducted in Women With Atopic Dermatitis (AD)
📍 Regeneron Research Site — Boston, Massachusetts
Adverse Pregnancy Outcomes
View Study & Checklist ➔A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
📍 University of Alabama at Birmingham - School of Medicine- Site Number : 8400003 — Birmingham, Alabama
Chronic Obstructive Pulmonary Disease
View Study & Checklist ➔Using Dupilumab to Improve Circadian Function, Sleep and Pruritus in Children With Moderate/Severe Atopic Dermatitis
📍 Lurie Children's Hospital/Northwestern University — Chicago, Illinois
Atopic Dermatitis
View Study & Checklist ➔A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
📍 Cahaba Dermatology & Skin Health Center /ID# 263855 — Birmingham, Alabama
Atopic Dermatitis
View Study & Checklist ➔A Study to Assess Adverse Events and Change in Disease Activity Comparing Oral Upadacitinib to Subcutaneous Dupilumab in Children From 2 to Less Than 12 Years of Age With Moderate to Severe Atopic Dermatitis
📍 Applied Research Center and Wellness Clinic /ID# 268547 — Little Rock, Arkansas
Atopic Dermatitis
View Study & Checklist ➔Measuring the Effect of Dupilumab Treatment on Mucociliary Clearance (MCC) in Subjects With Moderate to Severe Asthma
📍 The University of Pittsburgh Asthma Institute at UPMC — Pittsburgh, Pennsylvania
Asthma
View Study & Checklist ➔Dupilumab Versus Topical Corticosteroid Effectiveness - Comparison in the Treatment of Stenotic EoE
📍 Children's Hospital Colorado/University of Colorado School of Medicine — Aurora, Colorado
Eosinophilic Esophagitis
View Study & Checklist ➔Neoadjuvant Dupilumab and Toripalimab in MSS CRC Subjects With Resectable Liver Metastases
📍 Icahn School of Medicine at Mount Sinai — New York, New York
Metastatic Colorectal Cancer
View Study & Checklist ➔